Ezetimibe Tablet
FDA Label NDC 71335-0684

28 label sections · Submitted to the FDA by Bryant Ranch Prepack · Indications, Dosage, Usage, and Precautions

Structured Product Label

The following Structured Product Label (SPL) was submitted to the FDA by Bryant Ranch Prepack for the product Ezetimibe (NDC 71335-0684). This document serves as the official prescribing information, containing essential scientific data and clinical materials required for healthcare providers and patients.

This specific version of the label includes detailed information regarding 1 indications and usage, 2 dosage and administration, 3 dosage forms and strengths, 4 contraindications, 5.1 risks associated with combination treatment with a statin, fenofibrate, or other ldl-c lowering therapies, 5.2 liver enzymes, 5.3 myopathy/rhabdomyolysis, 6 adverse reactions, and other regulatory disclosures. Use the navigation below to review specific sections of the FDA submission.

Package Label.Principal Display Panel

Ezetimibe 10 mg Tablets

Label (Lbl713350684)

Label (Lbl713350684)

* Please review the disclaimer below.